Great result, +32% growth for the 3 months to July, plus this commentary suggests full year 2024 growth will likely come in higher:
"Commencing July 2023, the Company expanded its sales targeting to include inactive, existing customer accounts. The adoption rate amongst this group of surgeons has been strong, leading to an acceleration in USA sales growth that is expected to continue as the Company further expands its sales targeting to include new customer account acquisition in late 2023."
Nova will finally have it's day in the sun!!!
Ann: i Track Advance Sales in the USA, page-2
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.91M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $110.1K | 458.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 432506 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 169560 | 3 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |